Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Nutex Health (NUTX) Profit After Tax (2016 - 2026)

Nutex Health (NUTX) has disclosed Profit After Tax for 17 consecutive years, with $62.8 million as the latest value for Q1 2026.

  • For Q1 2026, Profit After Tax rose 195.81% year-over-year to $62.8 million; the TTM value through Mar 2026 reached $297.1 million, up 157.44%, while the annual FY2025 figure was $180.4 million, 90.24% up from the prior year.
  • Profit After Tax hit $62.8 million in Q1 2026 for Nutex Health, down from $121.4 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $121.4 million in Q4 2025 and bottomed at -$422.9 million in Q3 2022.
  • Average Profit After Tax over 5 years is -$3.8 million, with a median of -$542000.0 recorded in 2024.
  • Year-over-year, Profit After Tax tumbled 667.71% in 2022 and then surged 4014.58% in 2025.
  • Nutex Health's Profit After Tax stood at -$10.7 million in 2022, then crashed by 159.99% to -$27.7 million in 2023, then soared by 460.75% to $100.0 million in 2024, then rose by 21.44% to $121.4 million in 2025, then tumbled by 48.3% to $62.8 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods came in at $62.8 million, $121.4 million, and $96.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.